ENTITY

TuHURA Biosciences (HURA US)

11
Analysis
Health Care • United States
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company. The Company focuses on developing technologies to overcome resistance to cancer immunotherapy. TuHURA Biosciences operates in the United States.
more
bullish•TuHURA Biosciences
•06 Feb 2025 10:38•Issuer-paid

TuHURA Biosciences, Inc. - Initiating an Immune Response

TuHURA is a clinical-stage, oncology-focused biotechnology company ad-vancing innate immune agonists, checkpoint inhibitors & antibody-drug...

Share
x